☆ 4.5 Editorial Material

Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab

OSTEOPOROSIS INTERNATIONAL (2020)

Get Full Text
Add to Collection

Journal

OSTEOPOROSIS INTERNATIONAL
Volume 31, Issue 6, Pages 1019-1021

Publisher

SPRINGER LONDON LTD
DOI: 10.1007/s00198-020-05379-z

Keywords

-

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.